Designing Durable Remissions in Relapsed AML and Follicular Lymphoma
Oct 1, 2026 - 16:00
Radio and PodcastLive Radio & PodcastsScience & Medicine
New Approaches: Marstacimab Therapy and HLH Biomarkers
In this week's episode, Blood editor Dr. James Griffin interviews Drs. Johnny Mahlangu and Joseph Rocco on their articles published in volume 147 issue 9 of Blood . Dr. Mahlangu discusses study details and next steps fro...
Related Episodes
Continue listening to more episodes from Blood Podcast.
Dose Makes the Cure: Venetoclax in Ph- ALL
Sep 24, 2026 - 14:21
Exploiting Vulnerabilities in High‑Risk MM and Mapping the Red Cell Interactome
Sep 17, 2026 - 30:19
MYB driven ALL and Venetoclax-Azacitidine damage to Bone Marrow
Sep 10, 2026 - 24:34
Predictive Markers of Glofitamab Resistance in R/R B-NHL
Sep 3, 2026 - 15:41